血检及早发现卵巢癌

yuji8

Blood test detects ovarian cancer early
血检及早发现卵巢癌
NEW YORK (Reuters Health) - Researchers have developed what they believe is the first blood test that accurately detects ovarian cancer at an early stage.
纽约（健康路透通讯社）——研究人员已经研发出他们认为能够精确检测出早期卵巢癌的首个血液测试方法。
\"The ability to recognize almost 100 percent of new tumors will have a major impact on the high death rates of this cancer,\" senior author Dr. Gil Mor, from Yale University School of Medicine in New Haven, Connecticut, said in a statement. \"We hope this test will become the standard of care for women having routine examinations.\"
来自康涅狄格州纽黑文市耶鲁大学医学院的资深作者Gil Mor博士，在一份声明中说：“这种测试能够识别几乎100%新发肿瘤从而对这种高死亡率的卵巢癌有着巨大的冲击力，我们希望这种测试能成为标准常规的方法。
In 2005, Mor's team first described a panel of biomarkers that can detect stage I and II ovarian cancer.
2005年，Mor小组成员第一次阐述了能够检测出I期和II期卵巢癌的生物标记。
In the present trial, reported in the medical journal Clinical Cancer Research, the researchers expanded the panel from four proteins to six, and used a sophisticated assay system to measure protein levels in 362 healthy women and 156 patients newly diagnosed with ovarian cancer.
据《临床肿瘤研究》医学杂志报道，在目前的实验中，研究者们把这种生物标记从四种蛋白扩大到六种，用一复杂的检测体系检测了362名健康妇女和156名新诊断为卵巢癌的妇女的蛋白水平。
Alone, none of the biomarkers could distinguish the cancer patients from the healthy comparison group, the researchers report. When all six biomarkers were measured, however, the test identified 95 percent of the cancer patients.
研究人员指出，只是，没有一个标记物能够从健康对照组中鉴别出癌症患者，然而，当对这六种蛋白都检测时，95%的癌症患者能够确诊。
A larger evaluation of the biomarker assay is currently underway.
一场规模更大的生物标记物检测系统目前正在评审中。